RE:RE:Phase 1/2 AMBUSH Trial The Ambush Phase 1/2 clinical trialis looking at the combination of bortezomib, dexamethasone, and pembrolizumab with or without pelareorep in treating patients with multiple myeloma that has come back (relapsed) or does not response to treatment (refractory) (RRMM).
https://clinicaltrials.gov/ct2/show/NCT05514990